Centene's Multi-Year Recovery Underway, RBC Says

MT Newswires Live06-23 23:17

Centene (CNC) is seeing clear early signs of recovery this year after a disruptive 2025, RBC Capital Markets said in a note Tuesday.

Centene is progressing past a recent EPS trough, backed by factors including a Q1 adjusted EPS beat and a guidance raise to more than $3.40, which confirm that its "multi-year recovery is underway," according to the note.

RBC said it expects the company's Medicaid margin recovery to proceed as rates are catching up to medical cost trends.

The investment firm said it is also "encouraged" by the company's Marketplace margin outlook following pricing actions across Centene's Affordable Care Act book. It sees "tangible upside to 2026 EPS guidance if risk adjustment receivables hold."

RBC noted, however, Centene's shares appear to be "appropriately pricing in the recovery at current levels" after rising roughly 100% since the end of March.

The firm initiated coverage of Centene with a Sector Perform rating and a $70 price target.

Price: 63.51, Change: -0.17, Percent Change: -0.27

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2645837260?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 23:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645837260","market":"sh","top_or_hot":-1,"title":"Centene's Multi-Year Recovery Underway, RBC Says","media":"MT Newswires Live","content":"<html><body><p> Centene (CNC) is seeing clear early signs of recovery this year after a disruptive 2025, RBC Capital Markets said in a note Tuesday.</p><p>Centene is progressing past a recent EPS trough, backed by factors including a Q1 adjusted EPS beat and a guidance raise to more than $3.40, which confirm that its \"multi-year recovery is underway,\" according to the note.</p><p>RBC said it expects the company's Medicaid margin recovery to proceed as rates are catching up to medical cost trends.</p><p>The investment firm said it is also \"encouraged\" by the company's Marketplace margin outlook following pricing actions across Centene's Affordable Care Act book. It sees \"tangible upside to 2026 EPS guidance if risk adjustment receivables hold.\"</p><p>RBC noted, however, Centene's shares appear to be \"appropriately pricing in the recovery at current levels\" after rising roughly 100% since the end of March.</p><p>The firm initiated coverage of Centene with a Sector Perform rating and a $70 price target.</p><p>Price: 63.51, Change: -0.17, Percent Change: -0.27</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Centene's Multi-Year Recovery Underway, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCentene's Multi-Year Recovery Underway, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-23 23:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Centene (CNC) is seeing clear early signs of recovery this year after a disruptive 2025, RBC Capital Markets said in a note Tuesday.</p><p>Centene is progressing past a recent EPS trough, backed by factors including a Q1 adjusted EPS beat and a guidance raise to more than $3.40, which confirm that its \"multi-year recovery is underway,\" according to the note.</p><p>RBC said it expects the company's Medicaid margin recovery to proceed as rates are catching up to medical cost trends.</p><p>The investment firm said it is also \"encouraged\" by the company's Marketplace margin outlook following pricing actions across Centene's Affordable Care Act book. It sees \"tangible upside to 2026 EPS guidance if risk adjustment receivables hold.\"</p><p>RBC noted, however, Centene's shares appear to be \"appropriately pricing in the recovery at current levels\" after rising roughly 100% since the end of March.</p><p>The firm initiated coverage of Centene with a Sector Perform rating and a $70 price target.</p><p>Price: 63.51, Change: -0.17, Percent Change: -0.27</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2362541513.USD","symbol_name":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2645837260","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645837260","pubTimestamp":1782227861,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Centene  is seeing clear early signs of recovery this year after a disruptive 2025, RBC Capital Markets said in a note Tuesday.Centene is progressing past a recent EPS trough, backed by factors including a Q1 adjusted EPS beat and a guidance raise to more than $3.40, which confirm that its \"multi-year recovery is underway,\" according to the note.RBC said it expects the company's Medicaid margin recovery to proceed as rates are catching up to medical cost trends.The investment firm said it is also \"encouraged\" by the company's Marketplace margin outlook following pricing actions across Centene's Affordable Care Act book. It sees \"tangible upside to 2026 EPS guidance if risk adjustment receivables hold.\"RBC noted, however, Centene's shares appear to be \"appropriately pricing in the recovery at current levels\" after rising roughly 100% since the end of March.The firm initiated coverage of Centene with a Sector Perform rating and a $70 price target.Price: 63.51, Change: -0.17, Percent Chan","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","CNCG":"2倍做多CNC ETF-Leverage Shares","BK4588":"碎股","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","BK4154":"管理型保健护理","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","CNC":"康西哥","LU0859254822.USD":"T ROWE PRICE GLOBAL VALUE EQUITY \"A\" (USD) ACC","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU2357627491.SGD":"TRP GLOBAL VALUE EQUITY \"AH\" (SGDHDG) ACC","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","BK4585":"ETF&股票定投概念","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC"},"translate_title":"加拿大皇家银行表示，Centene的多年复苏正在进行中","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNC":1.5,"CNCG":0.6},"content_text":"Centene (CNC) is seeing clear early signs of recovery this year after a disruptive 2025, RBC Capital Markets said in a note Tuesday.Centene is progressing past a recent EPS trough, backed by factors including a Q1 adjusted EPS beat and a guidance raise to more than $3.40, which confirm that its \"multi-year recovery is underway,\" according to the note.RBC said it expects the company's Medicaid margin recovery to proceed as rates are catching up to medical cost trends.The investment firm said it is also \"encouraged\" by the company's Marketplace margin outlook following pricing actions across Centene's Affordable Care Act book. It sees \"tangible upside to 2026 EPS guidance if risk adjustment receivables hold.\"RBC noted, however, Centene's shares appear to be \"appropriately pricing in the recovery at current levels\" after rising roughly 100% since the end of March.The firm initiated coverage of Centene with a Sector Perform rating and a $70 price target.Price: 63.51, Change: -0.17, Percent Change: -0.27","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2645837260","isCrawlerRequest":true}